
Join to View Full Profile
4500 E 9th Ave710Denver, CO 80220
Phone+1 303-320-7826
Fax+1 303-320-7842
Are you Dr. Schwartzberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Barbara Schwartzberg, MD is a general surgeon in Denver, Colorado. She is currently licensed to practice medicine in Colorado and California.
Education & Training
- University of ColoradoResidency, Surgery, 1985 - 1990
- University of Colorado School of Medicine Anschutz Medical CampusClass of 1990
- George Washington University School of Medicine and Health SciencesClass of 1985
Certifications & Licensure
- CO State Medical License 1989 - 2025
- CA State Medical License 2017 - 2024
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 1 citationsCorrection to: Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations ...Barbara Schwartzberg, John M. Lewin, Osama Abdelatif, Jacqueline Bernard, Hanadi Bu-Ali
Annals of Surgical Oncology. 2018-12-17 - 6 citationsApplication of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).Barbara Schwartzberg, Daniel T. Chin, Paige L. Dorn, David S. Herron, Kathryn Howell
American Journal of Surgery. 2018-10-01 - 14 citationsPhase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations.Barbara Schwartzberg, John Lewin, Osama Abdelatif, Jacqueline Bernard, Hanadi Bu-Ali
Annals of Surgical Oncology. 2018-10-01
Authored Content
- Interstitial Laser Ablation as Alternative to Surgical Treatment of BenignOctober 2018
Press Mentions
- iCAD Launches New Initiatives Leveraging Unique Capabilities of Its Robust Product Portfolio to Reduce Health Care System Pressures During the COVID-19 PandemicMarch 23rd, 2020
- Independent, Long-Term Study Highlights Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer TreatmentOctober 1st, 2018
- Groundbreaking Breast Cancer Laser Treatment with Positive ResultsDecember 16th, 2015
- Join now to see all